JOHNSON & JOHNSON

Average Profitability
32.57%
Insider Buys Quantity
4
Insider Buys Sum
$17.87M
Insider Sells Quantity
2
Insider Sells Sum
$97.02M

Insider Activity of JOHNSON & JOHNSON

According to the SEC Form 4 filings, JOHNSON & JOHNSON, being in a position of

  1. 10 percent owner at CVRx, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 3725 shares for $96,142,
    over all time since 2024-02-16, has bought 0 shares, and sold 3725 shares for $96,142.

The largest purchase of all time was on 2016-08-16 and amounted to 583333 shares of Protagonist Therapeutics, Inc. for $7M.

The largest sale of all time was on 2015-06-08 and amounted to 2020530 shares of Nevro Corp. for $96.92M.

Biography of JOHNSON & JOHNSON

No biography is available at this moment.

2024-02-16SaleCVRx, Inc.
CVRX
10 percent owner
3,725
0.0203%
$25.81$96,142-56.72%
2016-08-16PurchaseProtagonist Therapeutics, Inc.
PTGX
10 percent owner
583,333
7.2004%
$12.00$7M+18.24%
2015-06-08SaleNevro Corp.
NVRO
10 percent owner
2.02M
7.9887%
$47.97$96.92M+15.28%
2015-03-18PurchaseMinerva Neurosciences, Inc.
NERV
10 percent owner
607,903
2.4657%
$4.93$3M-14.54%
2015-03-13PurchaseMinerva Neurosciences, Inc.
NERV
10 percent owner
1.22M
6.3714%
$5.29$6.43M+2.69%
2014-11-12PurchaseNevro Corp.
NVRO
10 percent owner
80,000
1.2919%
$18.00$1.44M+85.38%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.